Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

NCT02010801 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02010801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02010801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant liver tumors